STOCK TITAN

Ascend Wellness Stock Price, News & Analysis

AAWH OTC

Welcome to our dedicated page for Ascend Wellness news (Ticker: AAWH), a resource for investors and traders seeking the latest updates and insights on Ascend Wellness stock.

Ascend Wellness Holdings (AAWH) is a vertically integrated cannabis operator with cultivation, manufacturing, and retail facilities across seven U.S. states. This page provides investors and industry stakeholders with timely updates on corporate developments, financial performance, and market positioning.

Access official press releases and third-party analysis covering earnings reports, regulatory compliance milestones, product launches, and strategic partnerships. Our curated collection simplifies tracking AAWH's growth in medical and adult-use cannabis markets while maintaining strict compliance with financial disclosure standards.

Key updates include expansion announcements, operational efficiency improvements, and leadership changes. All content is verified for accuracy and relevance to support informed analysis of this multi-state operator's market trajectory.

Bookmark this page for streamlined access to AAWH's evolving story in the competitive cannabis sector. Check regularly for new developments impacting the company's operational footprint and industry standing.

News
Rhea-AI Summary

Ascend Wellness Holdings reported record revenue of $117.7 million in Q2 2022, a 16.2% quarter-over-quarter increase. Net revenue rose by 14.6% to $97.5 million, fueled by strong retail growth of 19.4% to $75.6 million and an impressive adjusted EBITDA margin expansion of 220 basis points to 21.4%. The net loss decreased to $21.2 million from $27.8 million in Q1 2022. Notable operational milestones include the launch of adult-use sales in New Jersey and expansions in Michigan, Ohio, and Pennsylvania, solidifying AWH's position as a leading cannabis operator.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.89%
Tags
-
Rhea-AI Summary

Ascend Wellness Holdings (AAWH) announced a definitive agreement to acquire Ohio Patient Access LLC, which is set to operate three dispensaries in Cincinnati, Piqua, and Sandusky. This move would expand AWH's footprint in Ohio to five dispensaries, the maximum allowed in the state. The CEO highlighted the strategic importance of growing in populous markets and the potential for adult-use cannabis sales in Ohio. Currently, AWH operates two dispensaries in Ohio and has a cultivation facility. Ohio's medical cannabis sales reached $381 million in 2021, marking a 72% increase from the previous year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.17%
Tags
-
Rhea-AI Summary

Ascend Wellness Holdings has officially opened its third medical dispensary in New Jersey, located in Fort Lee. The new facility spans over 3,400 square feet and features 29 registers to enhance efficiency. This expansion aims to meet the increasing demand for cannabis in the region and is strategically positioned across the Hudson River from New York City. Ascend Fort Lee will offer a full menu of cannabis products and is planning to transition to adult-use sales later this fall to serve both medical patients and recreational consumers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.07%
Tags
none
Rhea-AI Summary

Ascend Wellness Holdings, Inc. (AAWH) is set to hold a conference call on August 15, 2022, at 5:00 PM ET, to discuss its second quarter 2022 financial results following market close. Investors can join by dialing 1 (888) 390-0605 with the conference ID 06364687. A live audio webcast will also be available on the company's Investor Relations page. AWH operates in several states including Illinois, Michigan, and New Jersey, producing a range of cannabis products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.88%
Tags
-
Rhea-AI Summary

Ascend Wellness Holdings (AAWH) announced that its directors, Emily Paxhia, Scott Swid, and Joseph Hinrichs, collectively purchased approximately 60,352 Class A Common Shares between July 5 and July 6, 2022. This follows earlier purchases by CEO Abner Kurtin and President Frank Perullo. The company reassured stakeholders about its growth prospects despite market challenges, with the Board expressing confidence in Ascend's trajectory and the cannabis industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5%
Tags
management
-
Rhea-AI Summary

Ascend Wellness Holdings announced the purchase of 50,000 Class A Common Shares by AGP Partners, LLC at $2.05 per share on July 1, followed by 1,100 shares at $1.90 on July 4. AGP is associated with CEO Abner Kurtin and President Frank Perullo. Kurtin expressed confidence in AWH's future, leveraging current market conditions for strategic stock purchases while focusing on growth initiatives and financial performance, despite capital challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.98%
Tags
none
Rhea-AI Summary

Ascend Wellness Holdings (CSE: AAWH.U; OTCQX: AAWH) has closed on $28.5 million under its Senior Credit Facility, increasing total funding to $275 million. This funding will support near-term capital expenditures and acquisitions as the company expands its operations across the Midwest and Northeast. The loan carries a 9.5% interest rate, maturing in August 2025, and includes a warrant coverage of 20% on a $3.10 exercise price. CFO Dan Neville expressed optimism about leveraging this capital to enhance growth strategies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.65%
Tags
none
-
Rhea-AI Summary

Ascend Wellness Holdings, Inc. (CSE: AAWH.U) (OTCQX: AAWH) has successfully closed an additional $36.5 million in funding through its existing term loan credit facility to support growth initiatives. This follows the August 2021 announcement of a $210 million senior secured term loan. The new financing aims to enhance expansion efforts, particularly in Pennsylvania and the acquisition of MedMen NY. CFO Dan Neville emphasized ongoing exploration of financing options for growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Rhea-AI Summary

Ascend Wellness Holdings reported Q1 2022 net revenue of $85.1 million, a 3.8% decline from the previous quarter but a 28.7% increase year-over-year. Gross revenue totaled $101.2 million, reflecting a 0.8% quarter-over-quarter decrease and a 33.4% annual growth. The net loss widened to $27.8 million compared to $16.5 million in Q4 2021. Adjusted EBITDA stood at $16.4 million, down 17.1% quarter-over-quarter. The company expanded its operations into Pennsylvania and launched adult-use sales in New Jersey, marking a significant growth opportunity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.81%
Tags
Rhea-AI Summary

Ascend Wellness Holdings, Inc. (AWH) has signed a term sheet to resolve a lawsuit against MedMen NY, Inc., agreeing to acquire a 99.99% stake in MedMen NY. AWH will increase the transaction value by $15 million, bringing the total to $88 million, which remains below recent comparable deals. AWH will pay $74 million at closing, including a prior deposit, and an additional $14 million upon the first sale of adult-use cannabis. This acquisition marks AWH's entry into New York, enhancing its presence in the cannabis market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.65%
Tags
none

FAQ

What is the current stock price of Ascend Wellness (AAWH)?

The current stock price of Ascend Wellness (AAWH) is $0.29 as of June 18, 2025.

What is the market cap of Ascend Wellness (AAWH)?

The market cap of Ascend Wellness (AAWH) is approximately 75.7M.
Ascend Wellness

OTC:AAWH

AAWH Rankings

AAWH Stock Data

75.71M
121.29M
29.06%
11.62%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
New York